TrialScientific reports2016

A variation in KCNQ1 gene is associated with repaglinide efficacy on insulin resistance in Chinese Type 2 Diabetes Mellitus Patients.

Xueyan Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.